Zurich Cantonal Bank’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $637 | Sell |
49
-8,370
| -99% | -$109K | ﹤0.01% | 2545 |
|
2025
Q1 | $89.2K | Sell |
8,419
-180
| -2% | -$1.91K | ﹤0.01% | 2427 |
|
2024
Q4 | $146K | Sell |
8,599
-95
| -1% | -$1.61K | ﹤0.01% | 2287 |
|
2024
Q3 | $202K | Buy |
8,694
+846
| +11% | +$19.6K | ﹤0.01% | 2102 |
|
2024
Q2 | $191K | Sell |
7,848
-184
| -2% | -$4.48K | ﹤0.01% | 2058 |
|
2024
Q1 | $271K | Buy |
8,032
+392
| +5% | +$13.2K | ﹤0.01% | 1881 |
|
2023
Q4 | $241K | Sell |
7,640
-387
| -5% | -$12.2K | ﹤0.01% | 1978 |
|
2023
Q3 | $205K | Sell |
8,027
-4,754
| -37% | -$121K | ﹤0.01% | 1963 |
|
2023
Q2 | $367K | Buy |
12,781
+6,988
| +121% | +$200K | ﹤0.01% | 1540 |
|
2023
Q1 | $139K | Hold |
5,793
| – | – | ﹤0.01% | 2096 |
|
2022
Q4 | $98.2K | Buy |
5,793
+882
| +18% | +$15K | ﹤0.01% | 2282 |
|
2022
Q3 | $73K | Sell |
4,911
-27
| -0.5% | -$401 | ﹤0.01% | 2426 |
|
2022
Q2 | $78K | Sell |
4,938
-262
| -5% | -$4.14K | ﹤0.01% | 2401 |
|
2022
Q1 | $140K | Sell |
5,200
-26
| -0.5% | -$700 | ﹤0.01% | 2114 |
|
2021
Q4 | $193K | Buy |
5,226
+1
| +0% | +$37 | ﹤0.01% | 2087 |
|
2021
Q3 | $250K | Sell |
5,225
-52
| -1% | -$2.49K | ﹤0.01% | 1771 |
|
2021
Q2 | $179K | Buy |
5,277
+117
| +2% | +$3.97K | ﹤0.01% | 1874 |
|
2021
Q1 | $213K | Buy |
5,160
+3,061
| +146% | +$126K | ﹤0.01% | 1741 |
|
2020
Q4 | $91K | Buy |
2,099
+377
| +22% | +$16.3K | ﹤0.01% | 2249 |
|
2020
Q3 | $74K | Buy |
1,722
+936
| +119% | +$40.2K | ﹤0.01% | 2111 |
|
2020
Q2 | $37K | Buy |
+786
| New | +$37K | ﹤0.01% | 2293 |
|